Business Context and Reporting Period
Company: Prothena Corporation Public Limited Company (Ireland)
Filing Type: Form 8-K (Current Report)
Report Date: March 28, 2016
Event Date: March 22, 2016 (Sublease execution) and March 28, 2016 (Consent Agreement execution)
Context: Prothena Biosciences Inc. (PBI), a wholly owned subsidiary, entered into a material definitive agreement to sublease approximately 128,751 square feet of office and laboratory space in South San Francisco, California, from Amgen Inc. This move consolidates operations from the current facility (expiring November 30, 2020) to the new facility.
Key Financial Metrics and Terms
This filing details lease terms rather than historical financial performance. Key financial obligations and allowances include:
- Lease Term: Terminates December 31, 2023.
- Rent Commencement: Earlier of completion of improvements or August 1, 2016.
- Base Rent Schedule:
- Year 1: ~$5.4 million
- Year 2: ~$5.6 million
- Year 3: ~$5.7 million
- Subsequent Years: ~3% annual increase until Year 7, then fixed.
- Rent Abatements: ~$3.7 million in Year 1 and ~$1.3 million in Year 2.
- Improvement Allowance: ~$14.2 million total ($2.2 million from Master Landlord HCP BTC, LLC; $12.0 million from Sublandlord Amgen Inc.).
- Security: Standby letter of credit in the initial amount of ~$4.1 million.
Material Changes
The primary material change is the execution of the Sublease and Consent Agreement, enabling the relocation of PBI's operations. The filing does not provide comparative financial data (revenue, profit, cash flow) against prior periods as this is a transactional report, not a periodic financial statement.
Outlook, Risks, and Contingencies
- Operational Move: PBI intends to move all operations from the Current Facility to the New Facility.
- Cost Obligations: PBI is obligated to pay certain costs, taxes, and operating expenses related to the New Facility, subject to exclusions.
- Default Risk: The Sublandlord may draw down the $4.1 million standby letter of credit if PBI fails to perform obligations or cure defaults.
- Indemnification: PBI agreed to customary indemnification provisions regarding the use of and construction improvements on the New Facility.
Investor Verification Checklist
- Verify the exact "Rent Commencement Date" once improvements are completed or August 1, 2016, arrives.
- Confirm the total capitalized cost of the new facility improvements against the $14.2 million allowance.
- Review the upcoming Form 10-Q for the full text of the Sublease and Consent Agreement exhibits.
- Monitor the impact of the new lease obligations on future cash flow and liquidity.
- Check for any additional operating expense pass-throughs not detailed in this summary.